MRVI vs ZION · rev $117.3M vs P/E 11, rev $354.0M
Maravai Lifesciences Holdings Inc (MRVI) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
MRVI currently screens at market cap $1.93B. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the MRVI and ZION stock pages for the full models.
Not investment advice.